Background Dogs have a species‐specific susceptibility for developing mast cell tumours
(MCTs). Mutations in the KIT proto‐oncogene (KIT) are known to contribute to the neoplastic …

Molecular assays are widely used to prognosticate canine cutaneous mast cell tumors
(MCT). There is limited information about these prognostic assays used on MCT that arise in …

Cutaneous mast cell tumours (MCT) are among the most frequent malignancies in dogs.
Their clinical behaviour is highly variable and, with the exception of mutations in the c-kit …

The objective of this retrospective cohort study was to validate the prognostic value of
histological grading of canine cutaneous mast cell tumours (MCTs) according to the Patnaik …

Objectives To describe the clinicopathological and genetic characteristics of mast cell
tumours in dogs less than 12 months old. Materials and Methods Retrospective review of …

Cutaneous mast cell tumors (MCTs) are one of the most common tumors in dogs. Currently,
prognostic and therapeutic determinations for MCTs are primarily based on the histologic …

Mast cell tumor (MCT) is a common canine cutaneous neoplasm with variable biological
behavior. A 2-tier histologic grading system was recently proposed by Kiupel et al to reduce …

Background Canine cutaneous mast cell tumor (MCT) is a common neoplastic disease
associated with a variable biologic behavior. Surgery remains the primary treatment for …

Simple Summary In veterinary medicine, methods such as histological grading,
immunohistochemistry and mutation analysis of the c-kit gene are tools to assess the …

Background Distant metastases in dogs with cutaneous mast cell tumors (cMCT) are rare
and incurable. The aims of this prospective study were to clarify the clinico‐pathological …